FDA Strengthens Warnings on Two Diabetes Drugs (FREE)

By Kristin J. Kelley Edited by Susan Sadoughi, MD, and Richard Saitz, MD, MPH, FACP, FASAM Two drugs used to treat type 2 diabetes — canagliflozin and dapagliflozin — are associated with an increased risk for acute kidney injury, cautions the …
Source: Physician's First Watch current issue - Category: Primary Care Source Type: news